Kiora Pharmaceuticals Inc (EYEG)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
25-Oct-22 5:32 PM
View: 
Tosca Melissa
EVP of Finance
Kiora Pharmaceuticals Inc (EYEG) 21-Oct-22Grant 2,500----100%
0 to 2.5K
25-Oct-22 5:30 PM
View: 
Strem Brian M.
President and CEO
Director
Kiora Pharmaceuticals Inc (EYEG) 21-Oct-22Grant 12,500----1830%
0.68K to 13.18K
25-Oct-22 5:34 PM
View: 
Daniels Eric Joseph
Chief Development Officer
Kiora Pharmaceuticals Inc (EYEG) 21-Oct-22Grant 10,000----4202%
0.24K to 10.24K
06-Jan-22 5:10 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 05-Jan-22Payment of Exercise 114$1.08$123.12(< 1%)
22.97K to 22.85K
06-Jan-22 5:10 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 05-Jan-22Payment of Exercise 326$1.08$352.08(< 1%)
68.02K to 67.69K
08-Dec-21 4:15 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 07-Dec-21Payment of Exercise 91$1.30$118.30(< 1%)
23.06K to 22.97K
08-Dec-21 4:16 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 07-Dec-21Payment of Exercise 273$1.30$354.90(< 1%)
68.29K to 68.02K
22-Nov-21 4:35 PM
View: 
Strem Brian M.
President and CEO
Director
Kiora Pharmaceuticals Inc (EYEG) 18-Nov-21Private Purchase 17,853$1.41$25,172.70188%
9.52K to 27.37K
03-Nov-21 4:16 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 02-Nov-21Payment of Exercise 250$1.98$495.00(< 1%)
68.54K to 68.29K
(< 1%)
03-Nov-21 4:16 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 02-Nov-21Payment of Exercise 62$1.98$122.76(< 1%)
15.2K to 15.14K
(< 1%)
03-Nov-21 4:15 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 02-Nov-21Payment of Exercise 83$1.98$164.34(< 1%)
23.14K to 23.06K
(< 1%)
22-Nov-21 4:35 PM
View: 
Strem Brian M.
President and CEO
Director
Kiora Pharmaceuticals Inc (EYEG) 21-Oct-21Grant 9,517----100%
0 to 9.52K
05-Oct-21 6:40 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 04-Oct-21Payment of Exercise 62$2.01$124.62(< 1%)
15.26K to 15.2K
1%
05-Oct-21 6:40 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 04-Oct-21Payment of Exercise 83$2.01$166.83(< 1%)
23.23K to 23.14K
1%
05-Oct-21 6:39 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 04-Oct-21Payment of Exercise 249$2.01$500.49(< 1%)
68.79K to 68.54K
1%
03-Sep-21 4:16 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 02-Sep-21Payment of Exercise 84$1.81$152.04(< 1%)
23.31K to 23.23K
(9%)
03-Sep-21 4:17 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 02-Sep-21Payment of Exercise 253$1.81$457.93(< 1%)
69.04K to 68.79K
(9%)
03-Sep-21 4:15 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 02-Sep-21Payment of Exercise 61$1.81$110.41(< 1%)
15.32K to 15.26K
(9%)
04-Aug-21 5:46 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 03-Aug-21Payment of Exercise 261$2.40$626.40(< 1%)
69.31K to 69.04K
18%
04-Aug-21 5:46 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 03-Aug-21Payment of Exercise 65$2.40$156.00(< 1%)
15.44K to 15.38K
18%
04-Aug-21 5:45 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 03-Aug-21Payment of Exercise 63$2.40$151.20(< 1%)
15.38K to 15.32K
18%
04-Aug-21 5:45 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 03-Aug-21Payment of Exercise 87$2.40$208.80(< 1%)
23.4K to 23.31K
18%
03-Aug-21 10:00 PM
View: 
Armistice Capital, LLC
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 02-Aug-21Market Sale 192,775$2.40$463,046.00(20%)
977.77K to 785.0K
18%
03-Aug-21 10:00 PM
View: 
Armistice Capital, LLC
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 30-Jul-21Market Sale 68,188$2.69$183,562.00(7%)
1.05M to 977.77K
27%
29-Jul-21 7:59 PM
View: 
Armistice Capital, LLC
Director
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 29-Jul-21Market Sale 400,000$3.00$1,200,000.00(28%)
1.45M to 1.05M
34%
29-Jul-21 7:59 PM
View: 
Armistice Capital, LLC
Director
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 28-Jul-21Market Sale 375,443$3.28$1,232,620.00(21%)
1.82M to 1.45M
40%
29-Jul-21 7:59 PM
View: 
Armistice Capital, LLC
Director
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 27-Jul-21Conversion 852,500$4.80$4,092,000.0025%
3.35M to 4.2M
(59%)
29-Jul-21 7:59 PM
View: 
Armistice Capital, LLC
Director
10% Owner
Kiora Pharmaceuticals Inc (EYEG) 27-Jul-21Market Sale 2,377,700$5.09$12,113,600.00(57%)
4.2M to 1.82M
61%
06-Jul-21 10:00 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 02-Jul-21Payment of Exercise 160$3.70$592.00(1%)
15.6K to 15.44K
47%
06-Jul-21 10:00 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 02-Jul-21Payment of Exercise 180$3.70$666.00(< 1%)
23.58K to 23.4K
47%
06-Jul-21 10:00 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 02-Jul-21Payment of Exercise 877$3.70$3,244.90(1%)
70.18K to 69.31K
47%
07-Jun-21 5:02 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 04-Jun-21Payment of Exercise 180$4.19$754.20(< 1%)
23.76K to 23.58K
53%
07-Jun-21 5:01 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 04-Jun-21Payment of Exercise 155$4.19$649.45(< 1%)
15.69K to 15.54K
53%
07-Jun-21 5:02 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 04-Jun-21Payment of Exercise 878$4.19$3,678.82(1%)
71.06K to 70.18K
53%
07-Jun-21 5:01 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 04-Jun-21Payment of Exercise 155$4.19$649.45(< 1%)
15.76K to 15.6K
53%
05-May-21 9:57 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 04-May-21Payment of Exercise 889$4.13$3,671.57(1%)
71.95K to 71.06K
52%
05-May-21 9:57 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 04-May-21Payment of Exercise 158$4.13$652.54(< 1%)
15.92K to 15.76K
52%
05-May-21 9:57 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 04-May-21Payment of Exercise 177$4.13$731.01(< 1%)
23.93K to 23.76K
52%
05-May-21 9:56 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 04-May-21Payment of Exercise 191$4.13$788.83(1%)
15.88K to 15.69K
52%
09-Apr-21 4:16 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 08-Apr-21Payment of Exercise 180$4.94$889.20(< 1%)
24.11K to 23.93K
60%
09-Apr-21 4:15 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 08-Apr-21Payment of Exercise 192$4.94$948.48(1%)
16.08K to 15.88K
60%
09-Apr-21 4:16 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 08-Apr-21Payment of Exercise 899$4.94$4,441.06(1%)
72.85K to 71.95K
60%
09-Apr-21 4:16 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 08-Apr-21Payment of Exercise 194$4.94$958.36(1%)
16.11K to 15.92K
60%
05-Mar-21 4:31 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 03-Mar-21Payment of Exercise 218$5.46$1,190.28(< 1%)
24.33K to 24.11K
64%
05-Mar-21 4:31 PM
View: 
Mann Brenda
VP of Research & Development
Kiora Pharmaceuticals Inc (EYEG) 03-Mar-21Payment of Exercise 192$5.46$1,048.32(1%)
16.27K to 16.08K
64%
05-Mar-21 4:31 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 03-Mar-21Payment of Exercise 898$5.46$4,903.08(1%)
73.75K to 72.85K
64%
05-Mar-21 4:31 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 03-Mar-21Payment of Exercise 192$5.46$1,048.32(1%)
16.3K to 16.11K
64%
03-Feb-21 9:53 PM
View: 
From Stephen
Executive Chairman
Director
Kiora Pharmaceuticals Inc (EYEG) 02-Feb-21Payment of Exercise 3,542$6.34$22,456.30(5%)
77.29K to 73.75K
69%
03-Feb-21 9:53 PM
View: 
Manzo Michael P.
VP of Engineering
Kiora Pharmaceuticals Inc (EYEG) 02-Feb-21Payment of Exercise 990$6.34$6,276.60(6%)
17.29K to 16.3K
69%
03-Feb-21 9:53 PM
View: 
Romano Sarah
Chief Financial Officer
Kiora Pharmaceuticals Inc (EYEG) 02-Feb-21Payment of Exercise 1,282$6.34$8,127.88(5%)
25.61K to 24.33K
69%